X-1282753-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_172245.4(CSF2RA):c.50C>G(p.Ala17Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0664 in 1,613,236 control chromosomes in the GnomAD database, including 15,059 homozygotes. There are 50,831 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_172245.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.194 AC: 29461AN: 151968Hom.: 7334 Cov.: 31 AF XY: 0.187 AC XY: 13853AN XY: 74228
GnomAD3 exomes AF: 0.0782 AC: 19629AN: 251158Hom.: 3180 AF XY: 0.0669 AC XY: 9075AN XY: 135728
GnomAD4 exome AF: 0.0531 AC: 77589AN: 1461150Hom.: 7707 Cov.: 31 AF XY: 0.0508 AC XY: 36934AN XY: 726888
GnomAD4 genome AF: 0.194 AC: 29513AN: 152086Hom.: 7352 Cov.: 31 AF XY: 0.187 AC XY: 13897AN XY: 74356
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Benign:1
Ala17Gly in exon 4 of CSF2RA: This variant is not expected to have clinical sign ificance because it has been identified in 42.5% (1874/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs142270234). -
Surfactant metabolism dysfunction, pulmonary, 4 Benign:1
- -
CSF2RA-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at